Recombinant human erythropoietin plus methylprednisolone versus methylprednisolone in treatment of acute spinal cord injury:protocol for a systematic review and meta-analysis
Introduction Recent studies in animal models indicate that recombinant human erythropoietin (rHuEPO) is very effective in enhancing neurological recovery after spinal cord injury (SCI). We described a protocol aimed at evaluating the efficacy of rHuEPO plus methylprednisolone (MP) compared with MP a...
Saved in:
| Main Authors: | Yu He, Jiaojiao Zhou, Yong Zeng, Yonggang Zhang, Miao Fang, Shishu Huang, Yueming Song |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-12-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/12/12/e056689.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mega-dose methylprednisolone versus pulse methylprednisolone
by: Sinasi Ozsoylu
Published: (2014-04-01) -
Methylprednisolone Administration Following Spinal Cord Injury Reduces Aquaporin 4 Expression and Exacerbates Edema
by: Eibar Ernesto Cabrera-Aldana, et al.
Published: (2017-01-01) -
Serum erythropoietin and granulocyte-macrophage-colony stimulating factor levels with megadose methylprednisolone treatment
by: T R Sayli, et al.
Published: (1996-10-01) -
Methylprednisolone substituted lipid nanoparticles deliver C3 transferase mRNA for combined treatment of spinal cord injury
by: Haoru Dong, et al.
Published: (2025-02-01) -
Megadose methylprednisolone for hemangioma
by: Sinasi Ozsoylu
Published: (2010-10-01)